[go: up one dir, main page]

ME01516B - DERIVAT DIBENZOTIAZEPINA l NJEGOVA UPOTREBA - Google Patents

DERIVAT DIBENZOTIAZEPINA l NJEGOVA UPOTREBA

Info

Publication number
ME01516B
ME01516B MEP-2013-27A MEP2713A ME01516B ME 01516 B ME01516 B ME 01516B ME P2713 A MEP2713 A ME P2713A ME 01516 B ME01516 B ME 01516B
Authority
ME
Montenegro
Prior art keywords
disorder
dibenzothiazepine derivative
compound
compounds
dibenzothiazepine
Prior art date
Application number
MEP-2013-27A
Other languages
English (en)
Inventor
James R Damewood
James Hulsizer
James Campbell Muir
Jr M Edward Pierson
Ashokkumar Bhikkappa Shenvi
Dan Widzowski
Michael Wood
Dean Brown
Phil Edwards
Steven Wesolowski
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41431860&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ME01516(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of ME01516B publication Critical patent/ME01516B/me

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02—Seven-membered rings
    • C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D281/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D281/16—[b, f]-condensed

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Jedinjenje prema formuli I:   gde je Z kako je opisano u specifikaciji njegove farmaceutski prihvatljive soli, jedinjenja koja sadrže isto jedinjenje, te postupci za lečenje bipolarnog poremećaja, anksioznog poremećaja, poremećaja raspoloženja ili šizofrenije ili nekog drugog psihotičnog poremećaja sa pomenutim jedinjenima.  
MEP-2013-27A 2008-06-20 2009-06-18 DERIVAT DIBENZOTIAZEPINA l NJEGOVA UPOTREBA ME01516B (me)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7441708P 2008-06-20 2008-06-20
PCT/SE2009/050763 WO2009154563A1 (en) 2008-06-20 2009-06-18 Dibenzothiazepine derivatives and use thereof
EP09766953A EP2307389B1 (en) 2008-06-20 2009-06-18 Dibenzothiazepine derivative and use thereof

Publications (1)

Publication Number Publication Date
ME01516B true ME01516B (me) 2014-04-20

Family

ID=41431860

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-2013-27A ME01516B (me) 2008-06-20 2009-06-18 DERIVAT DIBENZOTIAZEPINA l NJEGOVA UPOTREBA

Country Status (37)

Country Link
US (3) US20110160184A1 (me)
EP (1) EP2307389B1 (me)
JP (2) JP5468068B2 (me)
KR (1) KR20110019781A (me)
CN (1) CN102131791B (me)
AR (1) AR072200A1 (me)
AU (1) AU2009260905B2 (me)
BR (1) BRPI0914231A2 (me)
CA (1) CA2728675A1 (me)
CL (1) CL2010001471A1 (me)
CR (1) CR11860A (me)
CU (1) CU23884B1 (me)
CY (1) CY1113845T1 (me)
DK (1) DK2307389T3 (me)
DO (1) DOP2010000393A (me)
EA (1) EA201001889A1 (me)
EC (1) ECSP10010698A (me)
ES (1) ES2402084T3 (me)
HN (1) HN2010002683A (me)
HR (1) HRP20130234T1 (me)
IL (2) IL210081A (me)
ME (1) ME01516B (me)
MX (1) MX2010014203A (me)
MY (1) MY157518A (me)
NI (1) NI201000224A (me)
NZ (1) NZ590616A (me)
PE (1) PE20110029A1 (me)
PL (1) PL2307389T3 (me)
PT (1) PT2307389E (me)
RS (1) RS52703B (me)
SI (1) SI2307389T1 (me)
SV (1) SV2010003769A (me)
TW (1) TWI488854B (me)
UA (1) UA105903C2 (me)
UY (1) UY31919A (me)
WO (1) WO2009154563A1 (me)
ZA (1) ZA201100488B (me)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY157518A (en) * 2008-06-20 2016-06-15 Astrazeneca Ab Dibenzothiazepine derivatives and use thereof
KR20160043029A (ko) * 2013-08-12 2016-04-20 그라파이트 소프트웨어 코포레이션 보안 인증 및 암호화된 도메인들로의 스위칭
CN103524455A (zh) * 2013-10-30 2014-01-22 苏州敬业医药化工有限公司 一种制备2-氯-二苯并[b,f][1,4]硫氮杂卓-11-[10H]酮的方法
CA2931289C (en) 2013-11-21 2023-10-17 Graphite Software Corporation Managed domains for remote content and configuration control on mobile information devices
CN104447615A (zh) * 2014-02-28 2015-03-25 广东东阳光药业有限公司 喹硫平中间体的制备方法
EP4428132A1 (en) * 2023-03-08 2024-09-11 Johann-Wolfgang-Goethe-Universität Frankfurt am Main Slack-activating compounds and their medical use
KR20250153284A (ko) * 2023-03-08 2025-10-24 요한 볼프강 괴테 우니베르시타트, 프랑크프루트 암 마인 슬랙(Slack) 활성화 화합물 및 이의 의학적 용도

Family Cites Families (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL294355A (me)
NL293201A (me)
DE1620703B2 (de) * 1960-08-16 1976-11-25 Ausscheidung aus: 12 80 879 Dr. A. Wander AG, Bern 11-basisch substituierte dibenzo eckige klammer auf b,f eckige klammer zu-eckige klammer auf 1,4 eckige klammer zu-thiazepine
CH422793A (de) * 1961-07-20 1966-10-31 Wander Ag Dr A Verfahren zur Herstellung 11-basisch substituierter Dibenzo(b,f) (1,4)thiazepine
DE1470416A1 (de) 1962-05-25 1969-05-14 Wander Ag Dr A Verfahren zur Herstellung ll-basisch substituierter 5 H-Dibenzo[b,e],[1,4] diazepine
CH476753A (de) 1962-06-08 1969-08-15 Wander Ag Dr A Verfahren zur Herstellung von 11-basisch substituierter Dibenzo(b,f)(1,4)thiazepine
NL140242B (nl) 1963-03-01 1973-11-15 Wander Ag Dr A Werkwijze voor het bereiden van op de 11-plaats door een basische groep gesubstitueerde dibenz (b.f.)(1.4) oxazepinen.
BE632120A (me) 1963-05-09
US3884920A (en) 1967-07-14 1975-05-20 Sandoz Ag 11-Basically substituted dibenz {8 b,f{9 {0 {8 1,4{9 {0 oxazepines
US3908010A (en) 1967-03-22 1975-09-23 Wander Ag Dr A Basically substituted heterocycles as anti-emetics
US3683034A (en) 1963-09-27 1972-08-08 Upjohn Co Process for the preparation of substituted hydroquinones
US3412193A (en) 1965-12-13 1968-11-19 American Cyanamid Co 11-(4-methyl-1-piperazinyl)dibenz[b, f][1, 4]oxazepines or thiazepines for controlling fertility
US3444169A (en) 1966-01-17 1969-05-13 American Cyanamid Co Process for 11 - aminodibenz(b,f)(1,4)oxazepines and analogous thiazepines
NL6715650A (me) 1966-12-16 1968-06-17
US3852446A (en) 1967-03-13 1974-12-03 Sandoz Ag Organic compounds in treatment of psychotic disturbances
US3539573A (en) * 1967-03-22 1970-11-10 Jean Schmutz 11-basic substituted dibenzodiazepines and dibenzothiazepines
US3758479A (en) 1967-03-22 1973-09-11 Sandoz Ag Nitro and sulphamoyl substituted dibenzodiazepines
US3962248A (en) * 1972-04-04 1976-06-08 Sandoz, Inc. Process for making 11-piperazino-diazepines, oxazepines, thiazepines and azepines
CH569730A5 (me) * 1972-04-04 1975-11-28 Wander Ag Dr A
GB8607684D0 (en) 1986-03-27 1986-04-30 Ici America Inc Thiazepine compounds
GB8705574D0 (en) 1987-03-10 1987-04-15 Ici Plc Preparation of thiazepine compound
JPH04211071A (ja) * 1990-03-05 1992-08-03 Hokuriku Seiyaku Co Ltd 多環式化合物
JPH0565257A (ja) 1991-07-05 1993-03-19 Hokuriku Seiyaku Co Ltd 多環式化合物及びその用途
US5661184A (en) 1994-08-12 1997-08-26 Eli Lilly And Company Psychiatric agents
ES2145922T3 (es) 1994-08-24 2000-07-16 Astrazeneca Ab Compuestos espiro-azabiciclicos utiles en terapia.
US5602121A (en) * 1994-12-12 1997-02-11 Allelix Biopharmaceuticals, Inc. Alkyl-substituted compounds having dopamine receptor affinity
SE9504661D0 (sv) 1995-12-22 1995-12-22 Astra Pharma Inc New compounds
SE9600683D0 (sv) 1996-02-23 1996-02-23 Astra Ab Azabicyclic esters of carbamic acids useful in therapy
AR013184A1 (es) 1997-07-18 2000-12-13 Astrazeneca Ab Aminas heterociclicas espiroazobiciclicas, composicion farmaceutica, uso de dichas aminas para preparar medicamentos y metodo de tratamiento o profilaxis
SE9702799D0 (sv) 1997-07-25 1997-07-25 Astra Ab New compounds
AU5489299A (en) 1998-08-18 2000-03-14 Sepracor, Inc. Use of hydroxyrisperidone for the manufacture of a medicament for the treatment and prevention of psychoses, emesis and symptoms of withdrawal from alcohol and nicotine
SE9900100D0 (sv) 1999-01-15 1999-01-15 Astra Ab New compounds
EP1200082A1 (de) 1999-07-28 2002-05-02 Oswald Wiss Präparate mit sauerstoffsparender wirkung bei körperlicher leistung
SE9903760D0 (sv) 1999-10-18 1999-10-18 Astra Ab New compounds
SE0002729D0 (sv) 2000-07-20 2000-07-20 Astrazeneca Ab Novel compound form
US6630462B2 (en) 2000-11-17 2003-10-07 Adolor Corporation Delta agonist analgesics
IL139975A0 (en) 2000-11-29 2002-02-10 Univ Ramot Anti proliferative drugs
IL158631A0 (en) 2001-05-18 2004-05-12 Astrazeneca Ab 4-(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
ATE353332T1 (de) 2001-06-01 2007-02-15 Astrazeneca Ab Neuer, für die therapie geeigneter ligand für nikotinische acetylcholinrezeptoren
KR20040026680A (ko) 2001-07-09 2004-03-31 콤비네이토릭스, 인코포레이티드 염증 질환 치료용 조합
EP1429844B1 (en) 2001-09-27 2012-01-18 Ramot at Tel Aviv University Ltd. Conjugate of perphenazine and gaba and uses thereof
US7544681B2 (en) 2001-09-27 2009-06-09 Ramot At Tel Aviv University Ltd. Conjugated psychotropic drugs and uses thereof
KR20040099446A (ko) 2002-04-18 2004-11-26 아스트라제네카 아베 헤테로시클릭 화합물
JP4511195B2 (ja) 2002-04-18 2010-07-28 アストラゼネカ・アクチエボラーグ フリル化合物
BR0309342A (pt) 2002-04-18 2005-02-15 Astrazeneca Ab Composto, composição farmacêutica, uso de um composto, e, método de tratamento ou profilaxia de doenças ou condições humanas
SE0202465D0 (sv) 2002-08-14 2002-08-14 Astrazeneca Ab New compounds
SE0202430D0 (sv) 2002-08-14 2002-08-14 Astrazeneca Ab New Compounds
SE0202598D0 (sv) 2002-09-02 2002-09-02 Astrazeneca Ab Alpha-7 Nicotinic receptor agonists and statins in combination
CN1681388A (zh) 2002-09-18 2005-10-12 Fmc有限公司 三环衍生物杀虫剂
AU2003290079A1 (en) 2002-12-20 2004-07-14 Basf Aktiengesellschaft Pesticidal dibenzo(hetero)azepine derivatives
KR20050092123A (ko) 2003-01-23 2005-09-20 아카디아 파마슈티칼스 인코포레이티드 Ｎ-데스메틸클로자핀의 인간의 신경정신성 질환의 치료용도
EP1495008A1 (en) 2003-02-22 2005-01-12 Teva Pharmaceutical Industries Limited Synthesis of quetiapine and pharmaceutically acceptable salts thereof
DE10310196A1 (de) 2003-03-06 2004-09-23 Rina-Netzwerk Rna Technologien Gmbh Verwendung eines trizyklischen Antidepressivums zur Förderung der Endozytose
JP2006523707A (ja) 2003-04-15 2006-10-19 アストラゼネカ アクツィエボラーグ 治療化合物
US20060217366A1 (en) * 2003-07-02 2006-09-28 Astrazeneca Ab Method of treating schizophrenia and other disorders
PL195728B1 (pl) 2003-07-18 2007-10-31 Helm Ag Sposób wytwarzania 11-(1-piperazynylo)dibenzo[b,f][1,4]tiazepiny
RU2394030C2 (ru) * 2003-12-22 2010-07-10 Акадиа Фармасьютикалз Инк. АМИНОЗАМЕЩЕННЫЕ АНАЛОГИ ДИАРИЛ [a,d] ЦИКЛОГЕПТЕНА В КАЧЕСТВЕ МУСКАРИНОВЫХ АГОНИСТОВ И СПОСОБЫ ЛЕЧЕНИЯ ПСИХОНЕВРОЛОГИЧЕСКИХ РАССТРОЙСТВ
ES2324713T3 (es) 2003-12-22 2009-08-13 Acadia Pharmaceuticals Inc. Analogos de diaril(a,d)ciclohepteno amino-sustituidos como agonistas muscarinicos y metodos de tratamiento de trastornos neuropsiquiatricos.
US20060063754A1 (en) * 2004-09-21 2006-03-23 Edgar Dale M Methods of treating a sleep disorder
CN101128435A (zh) 2004-12-27 2008-02-20 阿斯利康(瑞典)有限公司 作为代谢型谷氨酸受体激动剂用于治疗神经病学及精神病学病症的吡唑酮化合物
WO2006073360A1 (en) * 2005-01-07 2006-07-13 Astrazeneca Ab NEW USE OF 11-PIPERAZIN-1-YLDIBENZO [b,f] [1,4] THIAZEPINE OR ITS PHARMACEUTICALLY ACCEPTABLE SALT AND TO ORAL PHARMACEUTICAL COMPOSITIONS
WO2006107948A2 (en) * 2005-04-04 2006-10-12 Acadia Pharmaceuticals Inc. Use of n-desmethylclozapine and related compounds as dopamine stabilizing agents
WO2007053618A1 (en) * 2005-10-31 2007-05-10 Acadia Pharmaceuticals Inc. Prodrugs of muscarinic agonists and methods of treatment of neuropsychiatric disorders
JP2010514683A (ja) 2006-12-20 2010-05-06 アストラゼネカ・アクチエボラーグ 化合物及びその使用
US20110053953A1 (en) 2007-02-09 2011-03-03 Abdelmalik Slassi AZA-Isoindolones and Their Use as Metabotropic Glutamate Receptor Potentiators - 613
US7491871B2 (en) 2007-04-25 2009-02-17 Stine Seed Farm, Inc. Soybean cultivar S060299
TWI417100B (zh) 2007-06-07 2013-12-01 Astrazeneca Ab 二唑衍生物及其作為代謝型麩胺酸受體增效劑-８４２之用途
TW200911255A (en) 2007-06-07 2009-03-16 Astrazeneca Ab Metabotropic glutamate receptor oxadiazole ligands and their use as potentiators-841
MY157518A (en) * 2008-06-20 2016-06-15 Astrazeneca Ab Dibenzothiazepine derivatives and use thereof

Also Published As

Publication number Publication date
WO2009154563A1 (en) 2009-12-23
IL229560A0 (en) 2014-01-30
EP2307389B1 (en) 2013-01-23
EP2307389A4 (en) 2012-04-11
TW201002702A (en) 2010-01-16
UA105903C2 (uk) 2014-07-10
US20120202991A1 (en) 2012-08-09
PE20110029A1 (es) 2011-02-11
US20090318415A1 (en) 2009-12-24
NI201000224A (es) 2012-03-19
ES2402084T3 (es) 2013-04-26
CR11860A (es) 2011-02-25
UY31919A (es) 2010-01-29
DOP2010000393A (es) 2011-01-31
JP5468068B2 (ja) 2014-04-09
EA201001889A1 (ru) 2011-08-30
AR072200A1 (es) 2010-08-11
IL229560A (en) 2015-07-30
PL2307389T3 (pl) 2013-05-31
MY157518A (en) 2016-06-15
EP2307389A1 (en) 2011-04-13
CL2010001471A1 (es) 2011-05-06
CU20100252A7 (es) 2011-11-15
KR20110019781A (ko) 2011-02-28
BRPI0914231A2 (pt) 2015-11-03
US8158618B2 (en) 2012-04-17
DK2307389T3 (da) 2013-04-02
SV2010003769A (es) 2011-05-20
HRP20130234T1 (hr) 2013-04-30
HN2010002683A (es) 2013-01-15
CN102131791A (zh) 2011-07-20
ECSP10010698A (es) 2011-01-31
JP2014098006A (ja) 2014-05-29
IL210081A0 (en) 2011-02-28
US20110160184A1 (en) 2011-06-30
CU23884B1 (es) 2013-04-19
TWI488854B (zh) 2015-06-21
AU2009260905B2 (en) 2012-08-23
CY1113845T1 (el) 2016-07-27
AU2009260905A1 (en) 2009-12-23
NZ590616A (en) 2012-09-28
ZA201100488B (en) 2011-10-26
MX2010014203A (es) 2011-02-22
JP2011524898A (ja) 2011-09-08
PT2307389E (pt) 2013-03-28
US8653257B2 (en) 2014-02-18
SI2307389T1 (sl) 2013-04-30
RS52703B (sr) 2013-08-30
IL210081A (en) 2013-12-31
HK1156308A1 (en) 2012-06-08
CN102131791B (zh) 2014-12-24
CA2728675A1 (en) 2009-12-23

Similar Documents

Publication Publication Date Title
ME01516B (me) DERIVAT DIBENZOTIAZEPINA l NJEGOVA UPOTREBA
EA201071234A1 (ru) Производные изохинолинона в качестве nk3 антагонистов
EA201100424A1 (ru) Новые ингибиторы
CR20110032A (es) Derivados de tiofeno y tiazol y su uso como inhibidores de p13k
UY32049A (es) Inhibidores de cmet
NZ631419A (en) Inhibitors of hepatitis b virus covalently closed circular dna formation and their method of use
EA201100037A1 (ru) Органические соединения
EA201100875A1 (ru) Новые пиразол-4-n-алкоксикарбоксамиды в качестве микробиоцидов
MX2009001494A (es) 2-aminobenzoxazol carboxamidas como moduladores 5ht3.
EA201200653A1 (ru) Гетариламинохинолины
UY32331A (es) Compuestos novedosos como ligandos de receptores de canabinoides
CR20110013A (es) Derivados de Heteroarilo como Inhibidores de DGAT1
TN2009000249A1 (en) Mapk/erk kinase inhibitors
DE602008005141D1 (de) 1,3-dihydroimidazol-2-thionderivate als inhibitoren von dopamin-beta-hydroxylase
CL2011000846A1 (es) Compuestos heterociclicos sustituidos; composicion farmaceutica; y su uso para el tratamiento de la hepatitis c.
EA201171062A1 (ru) Алкиламидные соединения и их применение
UY33888A (es) Derivados de (1,2,4) triazolo [4,3-a) quinoxalina como inhibidores de fosfodiesterasas
EA201100612A1 (ru) Новые производные 2-амидотиадиазола
EA201201081A1 (ru) Производные гетарил[1,8]нафтиридина
MX2010002341A (es) Derivados de bencimidazol usados como agonistas del receptor x de farnesoide.
ATE531769T1 (de) Verwendung von estern als koaleszenzmittel
UA106880C2 (uk) Нові гербіциди
CO6551705A2 (es) Derivados de 3.4.4a.10b- tetrahidro-1h-tiopirano-[4.3-c]- isoquinolina
EA200901034A1 (ru) 6-БЕНЗИЛ-2,3,4,7-ТЕТРАГИДРОИНДОЛО [2,3-c]ХИНОЛИНЫ, ПРИМЕНИМЫЕ В КАЧЕСТВЕ ИНГИБИТОРОВ ФДЭ5 (ФОСФОДИЭСТЕРАЗЫ 5)
UA101018C2 (ru) Пирролопиримидинкарбоксамиды